Clinical Trials
2 trialsNCT04603807 2026-05-28
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT05170204 2026-05-06
HORIZON 1
Hoffmann-La Roche
Phase 3 Active not recruiting